BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

LEO Pharma 

Industriparken 55
DK-2750 Ballerup
Copenhagen      Denmark
Phone: 45-4492-3800 Fax: 45-4494-3040


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Antares Pharma, Inc. (ATRS) Receives Second Milestone Payment From LEO Pharma In OTREXUP Collaboration 3/12/2014 7:11:07 AM    More...
Antares Pharma, Inc. (ATRS) Announces LEO Pharma’s Launch Of OTREXUP (Methotrexate) Injection To Dermatologists For Adults With Psoriasis 3/10/2014 9:00:25 AM    More...
Antares Pharma, Inc. (AIS) Enters Into An Exclusive U.S. Promotion And Marketing Agreement With LEO Pharma For OTREXUP™ In Dermatology 11/14/2013 9:26:16 AM    More...
LEO Pharma Expands QualityCare™ Patient Support Program 10/28/2013 11:14:44 AM    More...
LEO Pharma Puts Patients at the Heart of Innovation 3/19/2013 10:14:23 AM    More...
Virobay Inc. and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis 3/18/2013 10:12:23 AM    More...
LEO Pharma Receives FDA Approval for Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for Body Plaque Psoriasis 10/26/2012 12:40:41 PM    More...
LEO Pharma Initiates Global Search for New Partners 6/14/2012 11:41:06 AM    More...
LEO Pharma Release: The New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses 3/15/2012 9:48:56 AM    More...
LEO Pharma Debuts Patient Assistance Program for Plaque Psoriasis Patients 3/6/2012 9:33:14 AM    More...
12345

//-->